Zhengye Biotechnology Holding Ltd
ZYBT
Analytical Summary
Zhengye Biotechnology Holding Ltd faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.
4-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Operating Margin (%)Operating Margin (%) is in the bottom quartile
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ |
|---|---|---|---|---|
| Revenue Growth YoY (%) |
-34.8%
Weak
Weak
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Below avg (-535%)
|
— | — | — |
| FCF Growth YoY (%) |
-54.7%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — |
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ |
|---|---|---|---|---|
| Operating Margin (%) (%) |
-60.6%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-504%)
|
8.8%
Caution
Caution
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-41%)
|
— | — |
| Effective Tax Rate (%) (%) |
-15.4%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
6.4%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — |
| Profit Margin (%) (%) |
-60.0%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-600%)
|
6.1%
Caution
Caution
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-49%)
|
— | — |
| FCF Margin (%) (%) |
10.6%
Fair
Fair
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
14.7%
Fair
Fair
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — |
| FCF / Net Income (x) |
-0.18x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.43x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ |
|---|---|---|---|---|
| Return on Invested Capital (%) |
-31.4%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
5.2%
Caution
Caution
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) |
-16.2%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
3.3%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — |
| Return on Common Equity (%) (%) |
-27.9%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-286%)
|
4.0%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-73%)
|
— | — |
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ |
|---|---|---|---|---|
| Debt to Equity (x) |
0.30x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-50%)
|
0.30x
Good
Good
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-49%)
|
— | — |
| Interest Coverage (x) |
-20.75x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
4.06x
Fair
Fair
Operating income divided by interest expense
Optimal:
> 5x
|
— | — |
| Net Debt (USD) | $10.68M | $9.29M | — | — |
| Debt / EBITDA (x) |
-1.51x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
2.32x
Fair
Fair
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— | — |
Secondary lens
Benchmark Lens
Compare ZYBT against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare ZYBT against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for ZYBT
No bullish signals detected
Operating Margin (%) is in the bottom quartile
Profit Margin (%) is in the bottom quartile
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How ZYBT compares to all companies
Peer Comparison
ZYBT vs similar peers
Compare ZYBT with peers
Stack ZYBT against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 4 years · 3 quarters